Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx (MDXG) EBT Margin (2016 - 2026)

Mimedx's EBT Margin history spans 16 years, with the latest figure at 25.99% for Q1 2026.

  • On a quarterly basis, EBT Margin fell 3575.0% to 25.99% in Q1 2026 year-over-year; TTM through Mar 2026 was 10.87%, a 460.0% decrease, with the full-year FY2025 number at 15.83%, down 59.0% from a year prior.
  • EBT Margin hit 25.99% in Q1 2026 for Mimedx, down from 18.46% in the prior quarter.
  • Over the last five years, EBT Margin for MDXG hit a ceiling of 26.62% in Q2 2024 and a floor of 25.99% in Q1 2026.
  • Historically, EBT Margin has averaged 6.15% across 5 years, with a median of 12.11% in 2024.
  • Biggest five-year swings in EBT Margin: soared 2745bps in 2023 and later plummeted -3575bps in 2026.
  • Tracing MDXG's EBT Margin over 5 years: stood at 13.25% in 2022, then increased by 21bps to 16.02% in 2023, then decreased by -24bps to 12.11% in 2024, then soared by 52bps to 18.46% in 2025, then tumbled by -241bps to 25.99% in 2026.
  • Business Quant data shows EBT Margin for MDXG at 25.99% in Q1 2026, 18.46% in Q4 2025, and 20.09% in Q3 2025.